Zusammenfassung
Die Therapie des vesikoureteralen Refluxes (VUR) hat sich in den letzten 10 Jahren stetig gewandelt. Offen-chirurgische Operationsverfahren wie z. B. die extravesikale Methode nach Lich-Gregoir oder die Ureterozystoneostomie im Psoas-Hitch-Verfahren, Referenzstandards mit sehr guten Erfolgsergebnissen, werden seltener angewandt. Die endoskopische Unterspritzung mit Dextranomer-Mikrosphären/Hyaluronsäure (Deflux®) hat sich seit ihrer Zulassung durch die US-amerikanische „Food and Drug Administration“ (FDA) 2001 zunehmend verbreitet. Kontrovers wird nach wie vor die Anwendung der sog. „bulking agents“ wie z. B. Deflux® beim dilatierenden und höhergradigen VUR diskutiert, während sie zunehmend beim niedriggradigen Reflux akzeptiert wird. Trotz höherer Rezidivraten bei allen VUR-Graden wird die „minimal-invasive Unterspritzung“ zunehmend häufiger angewendet. Letztlich muss die Frage beantwortet werden, von welcher Therapie (sofern nötig) der Patient am meisten profitiert. Welchen Stellenwert hat die endoskopische subureterale Unterspritzung erlangt und sind offene Operationen zur Therapie des VUR „out“?
Abstract
Therapy of vesicoureteral reflux (VUR) has steadily changed during the last decade. Open surgical procedures, e.g. extravesical reflux repair with the Lich-Gregoir technique or ureterocystoneostomy with the psoas hitch technique, reference standards with excellent success rates, are less frequently used. Since its approval by the US Food and Drug Administration (FDA) endoscopic reflux therapy with Deflux® has gained more and more popularity. However, the usage of so-called bulking agents, e.g. Deflux®, still remains controversial in dilating reflux, while its application for low-grade VUR is increasingly being accepted. Despite higher recurrence rates in all grades of VUR, the use of the “minimally invasive injection” is increasing. The question has to be answered which therapy – if necessary – benefits the patient most. Which role has the subureteral injection gained and are open surgical procedures for VUR therapy “out”?
Literatur
Aaronson IA, Rames RA, Greene WB et al (1993) Endoscopic treatment of reflux: migration of Teflon to the lungs and brain. Eur Urol 23(3):394–399
Atala A, Kavoussi LR, Goldstein DS et al (1993) Laparoscopic correction of vesicoureteral reflux. J Urol 150(2 Pt 2):748–751
Beetz R, Stein R (2007) Primärer vesikoureteraler reflux – 2. Therapeutische Konzepte. Pädiat Prax 70:615–630
Beetz R, Stein R (2007) Primärer vesikoureteraler Reflux – 1. Grundlagen und diagnostische Strategien. Pädiat Prax 70(2):255–276
Brandström P, Esbjörner E, Herthelius M et al (2010) The Swedish reflux trial in children: III. Urinary tract infection pattern. J Urol 184(1):286–291
Brühl P, Ahlen H van, Mallmann R (1988) Antireflux procedure by Lich-Gregoir. Indications and results. Eur Urol 14(1):37–40
Cerwinka WH, Scherz HC, Kirsch AJ (2008) Dynamic hydrodistention classification of the ureter and the double hit method to correct vesicoureteral reflux. Arch Esp Urol 61(8):882–887
Dodat H, Takvorian P, Mure PY et al (1995) Analysis of the failure of endoscopic treatment of vesico-renal reflux in children using injections of teflon and collagen and the preliminary results of injections of Macroplastic. Prog Urol 5(1):58–68
Edwards D, Normand IC, Prescod N, Smellie JM (1977) Disappearance of vesicoureteric reflux during long-term prophylaxis of urinary tract infection in children. Br Med J 2(6082):285–288
Elder JS, Diaz M, Caldamone AA et al (2006) Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 175(2):716–722
El-Ghoneimi A (2003) Paediatric laparoscopic surgery. Curr Opin Urol 13(4):329–335
Finnell SME, Carroll AE, Downs SM (2011) Technical report – diagnosis and management of an initial UTI in febrile infants and young children. Pediatrics 128:749–770, http://www.ncbi.nlm.nih.gov/pubmed/21873694
Gregoir W (1962) Congenital vesico-ureteral reflux. Acta Urol Belg 30:286–300
Gregoir W, Vanregenmorter G (1964) Congenital vesico-ureteral reflux. Urol Int 18:122–136
Holmdahl G, Brandström P, Läckgren G et al (2010) The Swedish reflux trial in children: II. Vesicoureteral reflux outcome. J Urol 184(1):280–285
Hsieh MH, Madden-Fuentes RJ, Lindsay NE, Roth DR (2010) Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon. Urology 76(1):199–203
Jodal U, Smellie JM, Lax H, Hoyer PF (2006) Ten-year results of randomized treatment of children with severe vesicoureteral reflux. Final report of the International reflux study in children. Pediatr Nephrol 21(6):785–792
Jodal U, Hansson S (1994) Urinary tract infection. In: Holliday MA, Barratt TM, Avner ED (eds) Pediatric Nephrology, 3. edn. Williams & Wilkins, Baltimore, pp 950–962
Jodal U, Lindberg U (1999) Guidelines for management of children with urinary tract infection and vesico-ureteric reflux. Recommendations from a Swedish state-of-the-art conference. Swedish Medical Research Council. Acta Paediatr 88(Suppl 431):87–89
Kirsch AJ (2011) Outpatient surgery for vesicoureteral reflux: endoscopic injection vs extravesical ureteral reimplantation. J Urol 186(5):1764–1765
Kirsch AJ, Perez-Brayfield MR, Scherz HC (2003) Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the children’s hospitals of Atlanta experience. J Urol 170(1):211–215
Krill AJ, Pohl HG, Belman AB et al (2011) Parental preferences in the management of vesicoureteral reflux. J Urol 186(5):2040–2044
Läckgren G (2011) What are my indications for endoscopic treatment of reflux? 31st Congress of the Societe International d’Urologie, Berlin
Lee EK, Gatti JM, Demarco RT, Murphy JP (2009) Long-term follow up of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup. J Urol 181(4):1869–1875
Lendvay TS, Sorensen M, Cowan CA et al (2006) The evolution of vesicoureteral reflux management in the era of dextranomer/hyaluronic acid copolymer: a pediatric health information system database study. J Urol 176(4 Pt 2):1864–1867
Lerner GR, Fleischmann LE, Perlmutter AD (1987) Reflux nephropathy. Pediatr Clin North Am 34(3):747–770
Linn R, Ginesin Y, Bolkier M, Levin DR (1989) Lich-Gregoir anti-reflux operation: a surgical experience and 5–20 years of follow-up in 149 ureters. Eur Urol 16(3):200–203
Malizia AA, Reiman HM, Myers RP et al (1984) Migration and granulomatous reaction after periurethral injection of polytef (Teflon). JAMA 251(24):3277–3281
Marotte JB, Smith DP (2001) Extravesical ureteral reimplantations for the correction of primary reflux can be done as outpatient procedures. J Urol 165(6 Pt 2):2228–2231
McAchran SE, Palmer JS (2005) Bilateral extravesical ureteral reimplantation in toilet trained children: Is 1-day hospitalization without urinary retention possible? J Urol 174(5):1991–1993
Merrick MV, Notghi A, Chalmers N et al (1995) Long-term follow up to determine the prognostic value of imaging after urinary tract infections. Part 2: scarring. Arch Dis Child 72(5):393–396
Molitierno JA, Scherz HC, Kirsch AJ (2008) Endoscopic treatment of vesicoureteral reflux using dextranomer hyaluronic acid copolymer. J Pediatr Urol 4(3):221–228
NCBI (2011) Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2–24 months. Pediatrics, http://www.ncbi.nlm.nih.gov/pubmed/21873693
Newman TB (2011) The new American Academy of pediatrics urinary tract infection guideline. Pediatrics 128:572–575, http://www.ncbi.nlm.nih.gov/pubmed/21873698
Palmer JS (2008) Extravesical ureteral reimplantation: an outpatient procedure. J Urol 180(4 Suppl):1828–1831
Palmer JS (2011) Outpatient surgery for vesicoureteral reflux: endoscopic injection vs extravesical ureteral reimplantation. J Urol 186(5):1765–1767
Peters CA, Skoog SJ, Arant BS et al (2010) Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 184(3):1134–1144
Puri P, Pirker M, Mohanan N et al (2006) Subureteral dextranomer/hyaluronic acid injection as first line treatment in the management of high grade vesicoureteral reflux. J Urol 176(4 Pt 2):1856–1860
Putman S, Wicher C, Wayment R et al (2005) Unilateral extravesical ureteral reimplantation in children performed on an outpatient basis. J Urol 174(5):1987–1990
Riedmiller H, Becht E, Hertle L et al (1984) Psoas-hitch ureteroneocystostomy: experience with 181 cases. Eur Urol 10(3):145–150
Riedmiller H, Riedmiller R, Jacobi G (1983) Therapie des vesiko-renalen Refluxes im Kindesalter. Dtsch Med Wochenschr 108:1522–1524
Routh JC, Inman BA, Reinberg Y (2010) Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review. Pediatrics 125(5):1010–1019
Schulman CC, Pamart D, Hall M et al (1990) Vesicoureteral reflux in children: endoscopic treatment. Eur Urol 17(4):314–317
Sillén U (1999) Bladder dysfunction in children with vesico-ureteric reflux. Acta Paediatr Suppl 88(431):40–47
Sillén U, Brandström P, Jodal U et al (2010) The Swedish reflux trial in children: bladder dysfunction. J Urol 184(1):298–304
Snodgrass W (1991) Relationship of voiding dysfunction to urinary tract infection and vesicoureteral reflux in children. Urology 38(4):341–344
Stein R, Beetz R, Thüroff J (2011) Kinderurologie in Klinik und Praxis, 3. Aufl. Thieme, Stuttgart
Stenberg A, Hensle TW, Läckgren G (2002) Vesicoureteral reflux: a new treatment algorithm. Curr Urol Rep 3(2):107–114
Vandenbossche M, Delhove O, Dumortier P et al (1993) Endoscopic treatment of reflux: experimental study and review of Teflon and collagen. Eur Urol 23(3):386–393
Wacksman J, Gilbert A, Sheldon CA (1992) Results of the renewed extravesical reimplant for surgical correction of vesicoureteral reflux. J Urol 148(2 Pt 1):359–361
Wicher C, Hadley D, Ludlow D et al (2010) 250 consecutive unilateral extravesical ureteral reimplantations in an outpatient setting. J Urol 184(1):311–314
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ziesel, C., Frees, S., Thüroff, J. et al. Therapieoptionen beim primären vesikoureteralen Reflux. Urologe 51, 352–356 (2012). https://doi.org/10.1007/s00120-012-2805-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-012-2805-x